Rectal Cancer Staging Using Whole Body MR-PET

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Rectal Cancer

Treatments

Procedure: MR-PET

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02651701
MRPET-CRC

Details and patient eligibility

About

The purpose of this study is to measure the diagnostic performance of whole body (WB) MR-PET for staging rectal cancer, compared with current standard of care (chest/abdominopelvic CT and rectal MRI) to investigate clinical feasibility of WB MR-PET as a one-stop preoperative imaging modality in patients with rectal cancer.

Enrollment

71 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adult patients newly diagnosed with rectal cancer on colonoscopy or sigmoidoscopy, who are potentially eligible for neoadjuvant chemoradiotherapy.
  2. Patients who sign informed consent.

Exclusion criteria

  1. Patients who are contraindication for CECT
  2. Patients who are contraindication for MRI/CE-MRI
  3. patients who are diagnosed with Tis or T1 cancer after polypectomy or EMR
  4. Patients who were already diagnosed with an active other cancers.
  5. Premenopausal female patients who are pregnant.
  6. Patients with fasting serum glucose level (>200mg/dL) on blood glucose meter prior to WB MR-PET.
  7. Patients who are physically compromised to undergo WB MR-PET.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems